Richwood Investment Advisors’s AbbVie ABBV Stock Holding History

Richwood Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,176	Closed	-$209K	–	98
2024 Q4	$209K	Sell	1,176 -340	-22%	-$62.5K	0.17%	98
2024 Q3	$299K	Hold	1,516	–	–	0.25%	82
2024 Q2	$260K	Sell	1,516 -60	-4%	-$9.94K	0.23%	88
2024 Q1	$287K	Sell	1,576 -97	-6%	-$16.7K	0.25%	86
2023 Q4	$259K	Sell	1,673 -125	-7%	-$18.2K	0.24%	90
2023 Q3	$268K	Hold	1,798	–	–	0.27%	87
2023 Q2	$242K	Hold	1,798	–	–	0.24%	93
2023 Q1	$287K	Sell	1,798 -260	-13%	-$39.8K	0.29%	92
2022 Q4	$333K	Sell	2,058 -93	-4%	-$14.3K	0.33%	81
2022 Q3	$289K	Sell	2,151 -170	-7%	-$24.4K	0.32%	84
2022 Q2	$356K	Hold	2,321	–	–	0.36%	78
2022 Q1	$376K	Hold	2,321	–	–	0.34%	81
2021 Q4	$314K	Buy	+2,321	New	+$274K	0.27%	84

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Richwood Investment Advisors's ABBV Position: Q1 2025 in Review

Richwood Investment Advisors sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 1,176 shares — an estimated $209K sold.

Richwood Investment Advisors first reported a position in ABBV in Q4 2021 and held it in 13 quarters. The position peaked at $376K in Q1 2022. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Richwood Investment Advisors reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
Richwood Investment Advisors sold 1,176 AbbVie shares in Q1 2025, an estimated $209K.
Richwood Investment Advisors first reported a position in AbbVie in Q4 2021 and held it in 13 quarters.
Richwood Investment Advisors's AbbVie position peaked at $376K in Q1 2022.
3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Richwood Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.